Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer-Reference-Cited by-同舟云学术

Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer

Published:2016 Issue:2 Volume:141 Page:669-678
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Chudziak Jakub¹²³⁴,Burt Deborah J.¹²³⁴,Mohan Sumitra¹²³⁴,Rothwell Dominic G.¹²³⁴,Mesquita Bárbara¹²³⁴,Antonello Jenny¹²³⁴,Dalby Suzanne¹²³⁴,Ayub Mahmood¹²³⁴,Priest Lynsey¹²³⁴,Carter Louise¹²³⁴,Krebs Matthew G.¹²³⁴,Blackhall Fiona⁵³⁴⁶⁷,Dive Caroline¹²³⁴,Brady Ged¹²³⁴

Affiliation:

1. Clinical and Experimental Pharmacology Group

2. Cancer Research UK Manchester Institute

3. Manchester

4. UK

5. Christie NHS Foundation Trust

6. Institute of Cancer Sciences

7. University of Manchester

Abstract

Evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells using clinical samples from patients with SCLC.

Funder

Cancer Research UK

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/AN/C5AN02156A

Reference33 articles.

1. Metastasis: a question of life or death

2. Dissecting the metastatic cascade

3. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System